Home/Committee Members/Dr. Saher Hashem

Dr. Saher Hashem

Consultant Neurologist, Head of Neurology Department Tunis, Tunisia

Dr. Saher Hashem
Dr. Saher HashemHonorary President of MENACTRIMS

Saher Hashem graduated from faculty of medicine at Cairo university MBBCH . Honors in the year 1967 and master of neuro psychiatry honors 1972 and neurology doctorate Cairo 1976 where he assigned as lecturer of neurology art Cairo University School of Medicine Kasr Alainy.

Prof. Hashem had 2 years post-doctoral training as research fellow in the USA in the years 1976 to 1978 in the field of stroke experimental and sonography and shared the modification of transcranial Doppler with Prof. James f tool in Winston Salem Wake Forest University.

Prof. Hashem assigned as assistant Prof. in neurology in the year 1981 where he started his interest in multiple sclerosis lecturing and helped in introducing the first MRI in Egypt in private practice and one of the steering committee of Cairo scan group. Prof. Saher received degree of Prof. Essor of neurology at Cairo University Kasr Alainy School of Medicine in 1986 till now and president of the department of neurology Cairo university till the year 2005 Nd president of the Egyptian society of neurology neurosurgery and psychiatry 2005–2007 and president of the pan Arab association for neuroscience from year 2007—-2009 and was appointed as head of neurology department in Benha University as well as Cairo University. In the year 2003 he with Prof. Farouk Talaat from Alexandria initiated the first Egyptian society for MS and he is the president of this society up till now. He is in the editorial board of JAMA neurology and chief editor of the Egyptian journal of neurology neuropsychiatry and psychiatry. He lectured everywhere in Egypt, Dubai, Saudi Arabia, Kuwait ,in different neurology aspects as well wrote over 50 articles in EJNNP ,add other international journals and supervised more the 60 master and doctorate thesis.

Prof. Hashem also shared international drug trials on DMD drugs in phase 3 used in treatment of MS.

About Us

MENACTRIMS is an independent organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS).

Know our Organization